Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01LPX
|
||||
Former ID |
DIB016317
|
||||
Drug Name |
Linotroban
|
||||
Synonyms |
CL-871502; HN-11500
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Thrombosis [ICD9: 437.6, 453, 671.5, 671.9; ICD10:I80-I82] | Discontinued in Phase 2 | [1] | ||
Company |
Nycomed AS
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C14H15NO5S2
|
||||
Canonical SMILES |
S(=O)(=O)(OCC(NC(=O)OCc1ccccc1)C(=O)OCC)c1ccc(cc1)C
|
||||
CAS Number |
CAS 120824-80-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Thromboxane A2 receptor | Target Info | Antagonist | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Platelet activation | |||||
Reactome | Prostanoid ligand receptors | ||||
G alpha (q) signalling events | |||||
G alpha (12/13) signalling events | |||||
Thromboxane signalling through TP receptor | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Signal amplification | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003261) | ||||
REF 2 | Effects of the novel thromboxane (TXA2) receptor antagonist linotroban on inulin and para-aminohippuric acid clearances in the conscious male and female rat. Arzneimittelforschung. 1997 Sep;47(9):1026-30. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.